Lupin net profit surges 52 percent at Rs 359 crore in Q4 Ruchika Sharma8 May 2024 3:16 PM ISTNew Delhi: Pharmaceutical giant Lupin has announced a notable 52 percent surge in consolidated net profit, reaching Rs 359 crore in the March...
Lupin bags USFDA nod for Travoprost Ophthalmic Solution Ruchika Sharma7 May 2024 11:43 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....
Lupin unveils Rymti biosimilar Etanercept in Canada Ruchika Sharma5 May 2024 10:00 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Rymti, Lupin's first biosimilar in Canada, through its partner Sandoz...
Lupin bags USFDA approval for Loteprednol Etabonate Ophthalmic Suspension Ruchika Sharma26 April 2024 11:40 AM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received approval from the United States Food and Drug...
USFDA issues EIR for Lupin Aurangabad facility Ruchika Sharma24 April 2024 11:46 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States...
Lupin unveils Mirabegron ER tablets in US Ruchika Sharma22 April 2024 12:09 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the United States, after...
USFDA concludes inspection of Lupin Dabhasa facility with no observations Ruchika Sharma13 April 2024 11:48 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a GMP...
Lupin unveils first generic version of Oracea in US Ruchika Sharma10 April 2024 11:15 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of first generic version of Oracea (Doxycycline Capsules, 40 mg), in the...
USFDA approves Lupin Valbenazine Capsules Ruchika Sharma9 April 2024 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....
Lupin names Dr Ranjana Pathak as Chief Quality Officer Ruchika Sharma3 April 2024 5:36 PM ISTMumbai: Global pharma major Lupin Limited today announced the appointment of Dr Ranjana Pathak as Chief Quality Officer, succeeding Johnny Mikell...
Lupin bags tentative USFDA nod for Migalastat Capsules Ruchika Sharma2 April 2024 12:30 PM ISTMigalastat Capsules are indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene...
Lupin bags USFDA nod for Eslicarbazepine Acetate Tablets for partial-onset seizures Ruchika Sharma29 March 2024 11:05 AM ISTEslicarbazepine Acetate Tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
